StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Equities research analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued on Wednesday. The brokerage set a “hold” rating on the stock.

Milestone Scientific Price Performance

MLSS opened at $0.57 on Wednesday. The stock has a market capitalization of $43.66 million, a price-to-earnings ratio of -5.70 and a beta of 0.97. The business has a 50-day moving average of $0.65 and a two-hundred day moving average of $0.70. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.35.

Milestone Scientific (NYSE:MLSS) last issued its earnings results on Friday, March 29th. The company reported ($0.03) earnings per share (EPS) for the quarter. The firm had revenue of $2.26 million for the quarter. Milestone Scientific had a negative return on equity of 86.72% and a negative net margin of 70.50%.

Institutional Investors Weigh In On Milestone Scientific

An institutional investor recently bought a new position in Milestone Scientific stock. AE Wealth Management LLC purchased a new stake in shares of Milestone Scientific Inc. (NYSE:MLSS) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 27,936 shares of the company’s stock, valued at approximately $26,000. Hedge funds and other institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.